Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Jefferson Research
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
iSonea Limited To Develop Asthma Mobile Health Technology With Qualcomm Inc
iSonea Limited announced that it will design and market a home and mobile asthma monitoring platform with telecommunications corporation Qualcomm Life Inc., a wholly owned subsidiary of Qualcomm Inc (NASDAQ: QCOM). The new technology will combine iSonea’s proprietary Acoustic Respiratory Monitoring (ARM) devices and mobile health asthma management systems with Qualcomm’s 2net platform. The integration will automatically and securely link patient asthma symptom and trend monitoring data to a cloud-based portal for physicians and caregivers, to improve asthma management and outcomes.
Latest Developments for Qualcomm Inc
- Qualcomm Inc Issues Q3 2013 Guidance In Line With Analysts' Estimates; Raises FY 2013 Guidance
- Qualcomm Inc Declares Quarterly Cash Dividend
- Qualcomm Inc Increases Quarterly Dividend By 40% and Announces New $5.0 Billion Stock Repurchase Program
- Qualcomm Inc Issues Q2 2013 Guidance In Line With Analysts' Estimates; Raises FY 2013 Guidance
- Share this
- Link this
- Digg this


Follow Reuters